Ordering Recommendation

Order in conjunction with von Willebrand Factor Antigen (0030285) and Factor VIII, Activity (0030095) as part of initial workup for suspected von Willebrand disease (VWD). Also useful for monitoring treatment in patients with VWD.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Light blue (sodium citrate).

Specimen Preparation

Transfer 0.5 mL citrated plasma to an ARUP standard transport tube. (Min: 0.3 mL) 
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.

Storage/Transport Temperature

CRITICAL FROZEN.

Unacceptable Conditions
Remarks
Stability

Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 2 weeks

Methodology

Quantitative Enzyme-Linked Immunosorbent Assay (ELISA)

Performed

Varies

Reported

7-10 days

Reference Interval

By Report

Interpretive Data



Compliance Category

Performed by non-ARUP Laboratory

Note

Hotline History

N/A

CPT Codes

85397

Components

Component Test Code* Component Chart Name LOINC
3004072 VWF GPIbM Activity
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • GP1bM
von Willebrand Factor (VWF) GPIbM Activity

Versiti Wisconsin, Inc